FDA grants accelerated approval to semaglutide (Wegovy) for MASH On Aug 15, 2025, the FDA approved Wegovy (semaglutide) injection for adults with MASH with moderate-to-advanced fibrosis, under the accelerated approval (See FDA announcement below.) The following is a summary of clinical trial data for resmetirom and semaglutide
If you want a proven weight loss medication right now, tirzepatide (Zepbound) and semaglutide (Wegovy) are FDA-approved, available by prescription, and produce meaningful results
This action benefits both the lymphatic system and fat cells, making it a revolutionary method for treating cellulite and stretch marks, helping to restore the skin to a toned and firm appearance
But theres a catch with that too (more on that later)
Tian J, Chen JH, Li Q, He Q, Lin WQ
SLU-PP-332 SLU-PP-332 is a small-molecule pan-agonist of estrogen-related receptors (ERR//) that stands out in preclinical studies for its exercise mimetic properties